Taiwan · Delayed Price · Currency is TWD WeLeader Biomedical Statistics
Total Valuation
TPEX:7713 has a market cap or net worth of TWD 3.32 billion. The enterprise value is 3.84 billion.
| Market Cap | 3.32B |
| Enterprise Value | 3.84B |
Important Dates
The last earnings date was Friday, March 13, 2026.
| Earnings Date | Mar 13, 2026 |
| Ex-Dividend Date | Mar 27, 2026 |
Share Statistics
TPEX:7713 has 45.48 million shares outstanding. The number of shares has increased by 11.38% in one year.
| Current Share Class | 45.48M |
| Shares Outstanding | 45.48M |
| Shares Change (YoY) | +11.38% |
| Shares Change (QoQ) | +12.27% |
| Owned by Insiders (%) | 19.02% |
| Owned by Institutions (%) | n/a |
| Float | 9.40M |
Valuation Ratios
The trailing PE ratio is 16.13.
| PE Ratio | 16.13 |
| Forward PE | n/a |
| PS Ratio | 2.99 |
| PB Ratio | 2.63 |
| P/TBV Ratio | 2.64 |
| P/FCF Ratio | 33.02 |
| P/OCF Ratio | 10.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.96, with an EV/FCF ratio of 38.17.
| EV / Earnings | 18.40 |
| EV / Sales | 3.46 |
| EV / EBITDA | 9.96 |
| EV / EBIT | 14.69 |
| EV / FCF | 38.17 |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.68.
| Current Ratio | 1.81 |
| Quick Ratio | 1.52 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 2.21 |
| Debt / FCF | 8.48 |
| Interest Coverage | 32.58 |
Financial Efficiency
Return on equity (ROE) is 19.23% and return on invested capital (ROIC) is 11.97%.
| Return on Equity (ROE) | 19.23% |
| Return on Assets (ROA) | 7.34% |
| Return on Invested Capital (ROIC) | 11.97% |
| Return on Capital Employed (ROCE) | 12.95% |
| Weighted Average Cost of Capital (WACC) | 3.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 201 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 6.81 |
Taxes
In the past 12 months, TPEX:7713 has paid 52.43 million in taxes.
| Income Tax | 52.43M |
| Effective Tax Rate | 20.09% |
Stock Price Statistics
The stock price has increased by +16.61% in the last 52 weeks. The beta is -0.01, so TPEX:7713's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | +16.61% |
| 50-Day Moving Average | 71.29 |
| 200-Day Moving Average | 69.44 |
| Relative Strength Index (RSI) | 62.81 |
| Average Volume (20 Days) | 14,227 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:7713 had revenue of TWD 1.11 billion and earned 208.56 million in profits. Earnings per share was 4.52.
| Revenue | 1.11B |
| Gross Profit | 370.97M |
| Operating Income | 261.22M |
| Pretax Income | 260.98M |
| Net Income | 208.56M |
| EBITDA | 289.42M |
| EBIT | 261.22M |
| Earnings Per Share (EPS) | 4.52 |
Balance Sheet
The company has 334.71 million in cash and 853.11 million in debt, with a net cash position of -518.40 million or -11.40 per share.
| Cash & Cash Equivalents | 334.71M |
| Total Debt | 853.11M |
| Net Cash | -518.40M |
| Net Cash Per Share | -11.40 |
| Equity (Book Value) | 1.26B |
| Book Value Per Share | 27.71 |
| Working Capital | 348.08M |
Cash Flow
In the last 12 months, operating cash flow was 313.30 million and capital expenditures -212.74 million, giving a free cash flow of 100.56 million.
| Operating Cash Flow | 313.30M |
| Capital Expenditures | -212.74M |
| Depreciation & Amortization | 28.20M |
| Net Borrowing | -60.21M |
| Free Cash Flow | 100.56M |
| FCF Per Share | 2.21 |
Margins
Gross margin is 33.44%, with operating and profit margins of 23.55% and 18.80%.
| Gross Margin | 33.44% |
| Operating Margin | 23.55% |
| Pretax Margin | 23.53% |
| Profit Margin | 18.80% |
| EBITDA Margin | 26.09% |
| EBIT Margin | 23.55% |
| FCF Margin | 9.07% |
Dividends & Yields
This stock pays an annual dividend of 4.10, which amounts to a dividend yield of 5.62%.
| Dividend Per Share | 4.10 |
| Dividend Yield | 5.62% |
| Dividend Growth (YoY) | 21.73% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 73.44% |
| Buyback Yield | -11.38% |
| Shareholder Yield | -5.72% |
| Earnings Yield | 6.28% |
| FCF Yield | 3.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:7713 has an Altman Z-Score of 2.74 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.74 |
| Piotroski F-Score | 6 |